-
Europe
The FCF Healthcare & Life Sciences Venture Capital Monitor – Europe is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies, displaying Venture capital financing trends in the European Healthcare & Life Sciences industry.
As of the end of October 2024 we identified the following current VC trends in Europe:
- Total Healthcare & Life Sciences funding reached EUR 31,125m
- Biotech/Pharma received 54% of the total investment volume (EUR 16,712m) with oncology being the leading indication (28%)
- In October Treeline Biosciences secured the highest transaction volume with EUR 381m, followed by Kailera Therapeutics with EUR 360m and Alpha-9 Oncology with EUR 159m
- RA Capital Management (United States) is the most active investor (by deal volume in 2024), followed by ARCH Venture Partners (United States) and Atlas Venture (United States)
Capital Markets Research
Healthcare & Life Sciences Venture Capital Monitor – Europe Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 09/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024”. The Monitor is a monthly published overview of venture capital trends in